ARCHIVES

Advances In Cancer Control Meeting Is Set For March 22

This article is from The Cancer Letter archive.

Vol. 15 No. 05 | February 3, 1989

Download PDF Visit The Full Archive

Related Articles

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013

Congress Holds Recision Hearings

February 28, 1975

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

March 5, 1999

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Rumors Preceded Broder’s Move

December 22, 1994